Pharmacologically active microcarriers for endothelial progenitor cell support and survival

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 81, Issue 3, 2012, Pages 609-616

  Musilli, Claudia ^a   Karam, Jean Pierre ^b,c   Paccosi, Sara ^a   Muscari, Claudio ^d   Mugelli, Alessandro ^a   Montero Menei, Claudia N ^b,c   Parenti, Astrid ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITÉ D'ANGERS   (France)

^c INSERM   (France)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Cell adhesion; Cell survival; Early endothelial progenitor cells; Endothelial cell proliferation and migration; Pharmacologically active microcarriers; VEGF A

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; POLYGLACTIN; VASCULOTROPIN A;

ARTICLE; CELL ADHESION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; ENDOTHELIAL PROGENITOR CELL; HUMAN; HUMAN CELL; MICROCARRIER CULTURE; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LACTIC ACID; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHORYLATION; POLY(ADP-RIBOSE) POLYMERASES; POLYGLYCOLIC ACID; STEM CELLS; TISSUE SCAFFOLDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84863774457     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2012.04.014     Document Type: Article

References (47)

1. A. Germani, C. Di Campli, G. Pompilio, P. Biglioli, M.C. Capogrossi, Regenerative therapy in peripheral artery disease, Cardiovasc. Ther. 27 (2009) 289-304.
2. W.S. Jones, B.H. Annex, Growth factors for therapeutic angiogenesis in peripheral arterial disease, Curr. Opin. Cardiol. 22 (2007) 458-463. (Pubitemid 47356953)
3. T. Murohara, H. Ikeda, J. Duan, S. Shintani, K. Sasaki, H. Eguchi, Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization, J. Clin. Invest. 105 (2000) 1527-1536. (Pubitemid 30390303)
4. S. Matoba, T. Tatsumi, T. Murohara, T. Imaizumi, Y. Katsuda, M. Ito, Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia, Am. Heart. J. 156 (2008) 1010-1018.
5. A. Zampetaki, J.P. Kirton, Q. Xu, Vascular repair by endothelial progenitor cells, Cardiovasc. Res. 78 (2008) 413-421. (Pubitemid 351769775)
6. G. Invernici, C. Emanueli, P. Madeddu, S. Cristini, S. Gadau, A. Benetti, et al., Human fetal aorta contains vascular progenitor cells capable of inducing vasculogenesis, angiogenesis, and myogenesis in vitro and in a murine model of peripheral ischemia, Am. J. Pathol. 170 (2007) 1879-1892. (Pubitemid 47339262)
7. M. Siepe, C. Heilmann, P. von Samson, P. Menasché, F. Beyersdorf, Stem cell research and cell transplantation for myocardial regeneration, Eur. J. Cardiothorac. Surg. 28 (2005) 318-324. (Pubitemid 41020706)
8. A. Aicher, C. Heeschen, K. Sasaki, C. Urbich, A.M. Zeiher, S. Dimmeler, Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: a new modality to increase efficacy of cell therapy in chronic hind limb ischemia, Circulation 114 (2006) 2823-2830. (Pubitemid 46018285)
9. K. Sasaki, C. Heeschen, A. Aicher, T. Ziebart, J. Honold, C. Urbich, Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy, Proc. Natl. Acad. Sci. USA 103 (2006) 14537-14541. (Pubitemid 44484785)
10. V.M. Tatard, M.C. Venier-Julienne, P. Saulnier, E. Prechter, J.P. Benoit, P. Menei, et al., Pharmacologically active microcarriers: a tool for cell therapy, Biomaterials 26 (2005) 3727-3737. (Pubitemid 40038168)
11. J.M. Anderson, M.S. Shive, Biodegradation and biocompatibility of PLA and PLGA microspheres, Adv. Drug Delivery Rev. 28 (1997) 5-24. (Pubitemid 27497671)
12. R.A. Jain, The manufacturing techniques of various drug loaded biodegradable poly(lactide-coglycolide) (PLGA) devices, Biomaterials 21 (2000) 2475-2490.
13. P. Menei, J.M. Pean, V. Nerriere-Daguin, C. Jollivet, P. Brachet, J.P. Benoit, Intracerebral implantation of NGF-releasing biodegradable microspheres protects striatum against excitotoxic damage, Exp. Neurol. 161 (2000) 259-272. (Pubitemid 30136548)
14. M.J. Mahoney, W.M. Saltzman, Transplantation of brain cells assembled around a programmable synthetic microenvironment, Nat. Biotechnol. 19 (2001) 934-939. (Pubitemid 32947571)
15. C. Jollivet, A. Aubert-Pouessel, A. Clavreul, M.C. Venier-Julienne, S. Remy, C.N. Montero-Menei, et al., Striatal implantation of GDNF releasing biodegradable microspheres promotes recovery of motor function in a partial model of Parkinson's disease, Biomaterials 25 (2004) 933-942. (Pubitemid 37376418)
16. G. Orive, E. Anitua, J.L. Pedraz, D.F. Emerich, Biomaterials for promoting brain protection, repair and regeneration, Nat. Rev. Neurosci. 10 (2009) 682-692.
17. V.M. Tatard, L. Sindji, J.G. Branton, A. Aubert-Pouëssel, J. Colleau, J.P. Benoit, et al., Pharmacologically active microcarriers releasing glial cell line-derived neurotrophic factor: survival and differentiation of embryonic dopaminergic neurons after grafting in hemiparkinsonian rats, Biomaterials 28 (2007) 1978-1988. (Pubitemid 46176173)
18. G.J. Delcroix, E. Garbayo, L. Sindji, O. Thomas, C. Vanpouille-Box, P.C. Schiller, et al., The therapeutic potential of human multipotent mesenchymal stromal cells combined with pharmacologically active microcarriers transplanted in hemi-parkinsonian rats, Biomaterials 32 (2011) 1560-1573.
19. C. Bouffi, O. Thomas, C. Bony, A. Giteau, M.C. Venier-Julienne, C. Jorgensen, et al., The role of pharmacologically active microcarriers releasing TGF-beta3 in cartilage formation in vivo by mesenchymal stem cells, Biomaterials 25 (2010) 6485-6493.
20. E. Garbayo, A.P. Raval, K.M. Curtis, D. Della-Morte, L.A. Gomez, G. D'Ippolito, et al., Neuroprotected properties of marrow-isolated adult multilineage inducible cells in rat hippocampus following global cerebral ischemia are enhanced when complexed to biomimetic microcarriers, J. Neurochem. 119 (2011) 972-988.
21. L. Bellik, F. Ledda, A. Parenti, Morphological and phenotypical characterization of human endothelial progenitor cells in an early stage of differentiation, FEBS Lett. 579 (2005) 2731-2736. (Pubitemid 40615685)
22. M.C. Vinci, L. Bellik, S. Filippi, F. Ledda, A. Parenti, Trophic effects induced by alpha-1d adrenoceptors on endothelial cells are potentiated by hypoxia, Am. J. Physiol. (Heart Circ. Physiol.) 293 (2007) H2140-H2147. (Pubitemid 47605855)
23. L. Morbidelli, A. Parenti, L. Giovannelli, H.J. Granger, F. Ledda, M. Ziche, B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF-2 effects, Br. J. Pharmacol. 124 (1998) 1286-1292. (Pubitemid 28333954)
24. L. Bellik, M.C. Vinci, S. Filippi, F. Ledda, A. Parenti, Intracellular pathways triggered by the selective Flt-1-agonist Placental Growth Factor in vascular smooth muscle cells exposed to hypoxia, Br. J. Pharmacol. 146 (2005) 568-575. (Pubitemid 41487073)
25. J.P. Kirton, Q. Xu, Endothelial precursors in vascular repair, Microvasc. Res. 79 (2010) 193-199.
26. T. Asahara, T. Murohara, A. Sullivan, M. Silver, R. van der Zee, T. Li, et al., Isolation of putative progenitor endothelial cells for angiogenesis, Science 275 (1997) 964-967. (Pubitemid 27087709)
27. Y.J. Woo, T.J. Grand, M.F. Berry, P. Atluri, M.A. Moise, V.M. Hsu, et al., Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy, J. Thorac. Cardiovasc. Surg. 130 (2005) 321-329. (Pubitemid 41074160)
28. A.A. Kocher, M.D. Schuster, M.J. Szabolcs, S. Takuma, D. Burkhoff, J. Wang, Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function, Nat. Med. 7 (2001) 430-436. (Pubitemid 32298545)
29. T. Asahara, H. Masuda, T. Takahashi, C. Kalka, C. Pastore, M. Silver, et al., Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization, Circ. Res. 85 (1999) 221-228. (Pubitemid 29377293)
30. P.C. Johnson, A.G. Mikos, J.P. Fisher, J.A. Jansen, Strategic directions in tissue engineering, Tissue Eng. 13 (2007) 2827-2837. (Pubitemid 350233087)
31. F. Caiado, T. Carvalho, F. Silva, C. Castro, N. Clode, J.F. Dye, et al., Differentiation and angiogenic growth factor production and the promotion of wound healing, Biomaterials 32 (2011) 7096-7105.
32. G. Grieb, D. Simons, H. Steinberger, A. Vollmar, J. Bernhagen, N. Pallua, Improved in vitro cultivation of endothelial progenitor cells as basis for dermal substitutes with enhanced angiogenic capabilities, Langenbecks Arch. Surg. 396 (2011) 1255-1262.
33. J. Saif, T.M. Schwarz, D.Y. Chau, J. Henstock, P. Sami, S.F. Leicht, Combination of injectable multiple growth factor-releasing scaffolds and cell therapy as an advanced modality to enhance tissue neovascularization, Arterioscler. Thromb. Vasc. Biol. 30 (2010) 1897-1904.
34. Q. Xiong, K.L. Hill, Q. Li, P. Suntharalingam, A. Mansoor, X. Wang, et al., A fibrin patch-based enhanced delivery of human embryonic stem cell-derived vascular cell transplantation in a porcine model of postinfarction left ventricular remodeling, Stem Cells 29 (2011) 367-375.
35. J.R. Frederick, J.R. Fitzpatrick 3rd, R.C. McCormick, D.A. Harris, A.Y. Kim, J.R. Muenzer, et al., Stromal cell-derived factor-1alpha activation of tissue-engineered endothelial progenitor cell matrix enhances ventricular function after myocardial infarction by inducing neovasculogenesis, Circulation 122 (Suppl. 11) (2010) S107-S117.
36. P. Losi, E. Briganti, A. Magera, D. Spiller, C. Ristori, B. Battolla, et al., Tissue response to poly(ether)urethane-polydimethylsiloxane-fibrin composite scaffolds for controlled delivery of pro-angiogenic growth factors, Biomaterials 31 (2010) 5336-5344.
37. A.L. Daugherty, L.K. Rangell, R. Eckert, J. Zavala-Solorio, F. Peale, R.J. Mrsny, Sustained release formulations of rhVEGF165 produce a durable response in a murine model of peripheral angiogenesis, Eur. J. Pharm. Biopharm. 78 (2011) 289-297.
38. V. Schächinger, B. Assmus, M.B. Britten, J. Honold, R. Lehmann, C. Teupe, et al., Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results on the TOPCARE-AMI trial, J. Am. Coll. Cardiol. 44 (2004) 1690-1699. (Pubitemid 39369805)
39. S. Dimmeler, J. Burchfield, A.M. Zeiher, Cell-based therapy of myocardial infarction, Arterioscler. Thromb. Vasc. Biol. 28 (2008) 208-216. (Pubitemid 351161191)
40. J. Hur, C.H. Yoon, H.S. Kim, J.H. Choi, H.J. Kang, K.K. Hwang, et al., Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis, Arterioscler. Thromb. Vasc. Biol. 24 (2004) 288-293. (Pubitemid 38197580)
41. C.H. Yoon, J. Hur, K.W. Park, J.H. Kim, C.S. Lee, I.Y. Oh, et al., Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases, Circulation 112 (2005) 1618-1627. (Pubitemid 41324524)
42. M. Germain, E.B. Affar, D. D'Amours, V.M. Dixit, G.S. Salvesen, G.G. Poirier, Cleavage of automodified poly(ADP-ribose) polymerase during apoptosis. Evidence for involvement of caspase-7, J. Biol. Chem. 274 (1999) 28379-28384.
43. V.M. Tatard, P. Menei, J.P. Benoit, C.N. Montero-Menei, Combining polymeric devices and stem cells for the treatment of neurological disorders: a promising therapeutic approach, Curr. Drug Targets 6 (2005) 81-96. (Pubitemid 40394326)
44. E.S. Wijelath, S. Rahman, J. Murray, Y. Patel, G. Savidge, M. Sobel, Fibronectin promotes VEGF-induced CD34p cell differentiation into endothelial cells, J. Vasc. Surg. 39 (2004) 655-660. (Pubitemid 38298639)
45. X. Shi, Y. Wang, L. Ren, C. Lai, Y. Gong, D.A. Wang, A novel hydrophilic poly(lactide-co-glycolide)/lecithin hybrid microspheres sintered scaffold for bone repair, J. Biomed. Mater. Res. A 92 (2010) 963-972.
46. E. Garbayo, C.N. Montero-Menei, E. Ansorena, J.L. Lanciego, M.S. Aymerich, M.J. Blanco-Prieto, Effective GDNF brain delivery using microspheres a promising strategy for Parkinson's disease, J. Control. Release 135 (2009) 119-126.
47. R. de Boer, A.M. Knight, A. Borntraeger, M.N. Hébert-Blouin, R.J. Spinner, M.J. Malessy, et al., Rat sciatic nerve repair with a poly-lactic-co-glycolic acid scaffold and nerve growth factor releasing microspheres, Microsurgery 31 (2011) 293-302.